{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T20:07:41Z","timestamp":1763755661945,"version":"3.45.0"},"reference-count":26,"publisher":"Oncology Nursing Society (ONS)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncology Nursing Forum"],"published-print":{"date-parts":[[2013,1,1]]},"DOI":"10.1188\/13.onf.17-19","type":"journal-article","created":{"date-parts":[[2012,12,26]],"date-time":"2012-12-26T21:02:26Z","timestamp":1356555746000},"page":"17-19","source":"Crossref","is-referenced-by-count":3,"title":["Nail Toxicity Associated With Paclitaxel Treatment for Ovarian Cancer"],"prefix":"10.1188","volume":"40","author":[{"given":"Karen K.","family":"Swenson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine M.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2012,12,26]]},"reference":[{"key":"1","unstructured":"Bristol-Myers Squibb. (2011). <i>Taxol\u00ae (paclitaxel) injection<\/i> [Package insert]. Retrieved from <a target=\"_blank\" href='http:\/\/packageinserts.bms.com\/pi\/pi_taxol.pdf'>http:\/\/packageinserts.bms.com\/pi\/pi_taxol.pdf<\/a>"},{"key":"2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ejon.2011.06.007","article-title":"Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity","volume":"16","author":"G. Can","year":"2012","journal-title":"European Journal of Oncology Nursing"},{"key":"3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/1078155208096111","article-title":"Cutaneous reaction associated with weekly docetaxel administration","volume":"15","author":"L. Chew","year":"2009","journal-title":"Journal of Oncology Pharmacy Practice"},{"key":"4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1743-7563.2011.01467.x","article-title":"Capecitabine and weekly paclitaxel as first-line therapy in Thai patients with metastatic breast cancer","volume":"8","author":"I. Chitapanarux","year":"2012","journal-title":"Asia-Pacific Journal of Clinical Oncology"},{"key":"5","first-page":"81","article-title":"Managing simple chronic paronychia and onycholysis with ciclopirox 0.77% and an irritant-avoidance regimen","volume":"73","author":"C. Daniel, 3rd","year":"2004","journal-title":"Cutis: Cutaneous Medicine for the Practitioner"},{"key":"6","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1093\/annonc\/mdg419","article-title":"Onycholysis secondary to multiple paclitaxel one-hour infusions: Possible role for its vehicle (Cremophor EL)","volume":"14","author":"U. DeGiorgi","year":"2003","journal-title":"Annals of Oncology"},{"key":"7","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1345\/aph.18307","article-title":"Onycholysis associated with weekly administration of paclitaxel","volume":"33","author":"S. Flory","year":"1999","journal-title":"Annals of Pharmacotherapy"},{"key":"8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1046\/j.1468-3083.2003.00774.x","article-title":"Onycholysis and subungual haemorrhages secondary to systemic chemotherapy (paclitaxel)","volume":"17","author":"E. Ghetti","year":"2003","journal-title":"Journal of European Academy of Dermatology and Venereology"},{"key":"9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/1078155208100450","article-title":"Nail toxicity induced by cancer chemotherapy","volume":"15","author":"P. Gilbar","year":"2009","journal-title":"Journal of Oncology Pharmacy Practice"},{"key":"10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/sj.bjc.6601485","article-title":"Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer","volume":"90","author":"S. Gori","year":"2004","journal-title":"British Journal of Cancer"},{"key":"11","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1002\/(SICI)1097-0142 (20000515)88:10","article-title":"Onycholysis as a complication of systemic chemotherapy: Report of five cases associated with prolonged weekly paclitaxel therapy and review of the literature","volume":"88","author":"S. Hussain","year":"2000","journal-title":"Cancer"},{"key":"12","first-page":"229","article-title":"Onycholysis associated with paclitaxel","volume":"71","author":"J. Mackay-Wiggan","year":"2003","journal-title":"Cutis: Cutaneous Medicine for the Practitioner"},{"key":"13","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1200\/JCO.2002.09.130","article-title":"Phase II trial of weekly single-agent paclitaxel in platinum\/paclitaxel-refractory ovarian cancer","volume":"20","author":"M. Markman","year":"2002","journal-title":"Journal of Clinical Oncology"},{"key":"14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ctrv.2009.10.006","article-title":"Overall survival benefit for weekly versus three-weekly taxanes regimens in advanced breast cancer: A meta-analysis","volume":"36","author":"D. Mauri","year":"2010","journal-title":"Cancer Treatment Review"},{"key":"15","unstructured":"MedicineNet. (1996-2012). MedTerms\u2122. Retrieved from <a target=\"_blank\" href='http:\/\/www.medterms.com\/script\/main\/hp.asp'>http:\/\/www.medterms.com\/script\/main\/hp.asp<\/a>"},{"key":"16","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00216-012-5866-1","article-title":"Investigation of the chemical composition-antibacterial activity relationship of essential oils by chemometric methods","volume":"403","author":"D. Miladinovic","year":"2012","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/annonc\/mdg050","article-title":"Taxane-induced nail changes: Incidence, clinical presentation and outcome","volume":"14","author":"A. Minisini","year":"2003","journal-title":"Annals of Oncology"},{"key":"18","first-page":"693","article-title":"Paclitaxel-induced nail changes: Possible role of its vehicle (Cremophor EL)","volume":"16","author":"E. Minutilli","year":"2006","journal-title":"European Journal of Dermatology"},{"key":"19","unstructured":"National Institutes of Health. (2012). ClinicalTrials.gov. Retrieved from <a target=\"_blank\" href='http:\/\/www.clinicaltrials.gov\/ct2\/results?term=NCT01167712&Search=Search'>http:\/\/www.clinicaltrials.gov\/ct2\/results?term=NCT01167712&Search=Search<\/a>"},{"key":"20","first-page":"262","article-title":"Paclitaxel-associated subungual pyogenic granuloma: Report in a patient with breast cancer receiving paclitaxel and review of drug-induced pyogenic granulomas adjacent to and beneath the nail","volume":"11","author":"L. Paul","year":"2012","journal-title":"Journal of Drugs in Dermatology"},{"key":"21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3349\/ymj.2007.48.1.124","article-title":"Docetaxel-induced onycholysis: The role of subungual hemorrhage and suppuration","volume":"48","author":"M. Roh","year":"2007","journal-title":"Yonsei Medical Journal"},{"key":"22","unstructured":"Sanofi Oncology. (2012). Taxotere\u00ae (docetaxel) injection concentrate. Retrieved from <a target=\"_blank\" href='http:\/\/products.sanofi.us\/Taxotere\/taxotere.html'>http:\/\/products.sanofi.us\/Taxotere\/taxotere.html<\/a>"},{"key":"23","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/cncr.23333","article-title":"Matched case control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot","volume":"112","author":"F. Scotte","year":"2008","journal-title":"Cancer"},{"issue":"6C","key":"24","first-page":"4721","article-title":"Phase I study of docetaxel administered by bi-weekly infusion to patients with metastatic breast cancer","volume":"20","author":"E. Shin","year":"2000","journal-title":"Anticancer Research"},{"key":"25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/IGC.0b013e318234fa3a","article-title":"Phase II study of docetaxel weekly in combination with carboplatin every three weeks as first-line chemotherapy in stage IIB to stage IV epithelial ovarian cancer","volume":"22","author":"B. Sorbe","year":"2012","journal-title":"International Journal of Gynecological Cancer"},{"key":"26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1016002329546","article-title":"Docetaxel-induced nail changes\u2014A neurogenic mechanism: A case report","volume":"58","author":"G. Wasner","year":"2002","journal-title":"Journal of Neuro-Oncology"}],"container-title":["Oncology Nursing Forum"],"original-title":[],"link":[{"URL":"http:\/\/ons.metapress.com\/index\/J24R37R23V361061.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:54:51Z","timestamp":1763754891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/onf\/40\/1\/nail-toxicity-associated-paclitaxel-treatment-ovarian-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,26]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1,1]]}},"alternative-id":["J24R37R23V361061"],"URL":"https:\/\/doi.org\/10.1188\/13.onf.17-19","relation":{},"ISSN":["0190-535X","1538-0688"],"issn-type":[{"type":"print","value":"0190-535X"},{"type":"electronic","value":"1538-0688"}],"subject":[],"published":{"date-parts":[[2012,12,26]]}}}